At a glance
ClinicalIndex Comparison RecordN/ACompleted· 4 enrolled
Drug / intervention
Radiation therapydevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Pilot Study to Evaluate Radiotherapy-Induced Ant-Tumor Immunity in Metastatic Carcinoma of the Pancreas
In Brief
A clinical study evaluating Radiation therapy for Histological or Cytological Diagnosis of Pancreatic Carcinoma. Completed, enrolled 4 participants across 1 site.
Detailed Summary
Primary Objective: To estimate the rate at which radiotherapy to the primary or a metastatic lesion produces an immune response in patients with metastatic carcinoma of the pancreas. Secondary Objectives: To characterize the kinetics of an immune response induced by radiotherapy. To characterize the dependency of the immune response on prior exposure to chemotherapy.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartJul 2013
First PostedNov 2013
Primary CompletionSep 2015
Study CompletionDec 2019
TodayJul 2026
First PostedNov 18, 2013
Enrollment StartJul 1, 2013
Primary CompletionSep 1, 2015
Study CompletionDec 1, 2019
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 12.6 years ago
Interventions
Radiation therapydevice